We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FMB icon
4626
First Trust Managed Municipal ETF
FMB
$2.06B
$3.07M ﹤0.01%
60,579
+17,852
+42% +$915K
SUSB icon
4627
iShares ESG Aware 1-5 Year USD Corporate Bond ETF
SUSB
$1.3B
$3.06M ﹤0.01%
+127,203
New +$3.09M
PAG icon
4628
PUT
Penske Automotive Group
PAG
$14.4B
$3.06M ﹤0.01%
29,200
+5,500
+23% +$590K
HDB icon
4629
PUT
HDFC Bank
HDB
$120B
$3.06M ﹤0.01%
111,200
-69,400
-38% -$1.96M
IOVA icon
4630
CALL
Iovance Biotherapeutics
IOVA
$3.16B
$3.05M ﹤0.01%
276,300
-160,800
-37% -$2.11M
SPYM
4631
State Street SPDR Portfolio S&P 500 ETF
SPYM
$169B
$3.05M ﹤0.01%
68,734
+64,434
+1,498% +$3.1M
MORN icon
4632
CALL
Morningstar
MORN
$7.78B
$3.05M ﹤0.01%
12,600
+4,200
+50% +$1.06M
BHVN
4633
PUT
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$3.04M ﹤0.01%
20,900
-99,400
-83% -$12.7M
PTCT icon
4634
PTC Therapeutics
PTCT
$5.98B
$3.04M ﹤0.01%
75,995
-18,312
-19% -$642K
DDS icon
4635
Dillards
DDS
$8.76B
$3.04M ﹤0.01%
13,794
+11,952
+649% +$3.45M
JAZZ icon
4636
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
$3.04M ﹤0.01%
19,500
-62,100
-76% -$9.56M
VIDI icon
4637
Vident International Equity Strategy
VIDI
$450M
$3.04M ﹤0.01%
136,623
+113,898
+501% +$2.81M
ARWR icon
4638
PUT
Arrowhead Research
ARWR
$12.2B
$3.04M ﹤0.01%
86,200
-1,600
-2% -$60.2K
DJT icon
4639
Trump Media & Technology Group
DJT
$2.3B
$3.03M ﹤0.01%
125,578
+119,570
+1,990% +$4.99M
ABG icon
4640
CALL
Asbury Automotive
ABG
$3.78B
$3.03M ﹤0.01%
17,900
-45,700
-72% -$7.91M
DTE icon
4641
PUT
DTE Energy
DTE
$29.3B
$3.03M ﹤0.01%
23,900
+10,400
+77% +$1.36M
LSPD icon
4642
Lightspeed Commerce
LSPD
$1.38B
$3.03M ﹤0.01%
+135,688
New +$3.19M
IXN icon
4643
PUT
iShares Global Tech ETF
IXN
$9.42B
$3.02M ﹤0.01%
66,200
+7,100
+12% +$359K
DPST icon
4644
CALL
Direxion Daily Regional Banks Bull 3X ETF
DPST
$417M
$3.02M ﹤0.01%
12,550
-2,190
-15% -$677K
AWTM
4645
DELISTED
AWTM Ultra-Short Duration Enhanced Income ETF
AWTM
$3.02M ﹤0.01%
62,104
+46,098
+288% +$2.25M
TMHC
4646
DELISTED
Taylor Morrison
TMHC
$3.02M ﹤0.01%
129,203
+30,299
+31% +$802K
EDIT icon
4647
PUT
Editas Medicine
EDIT
$433M
$3.01M ﹤0.01%
254,800
-35,900
-12% -$481K
FTXG icon
4648
First Trust Nasdaq Food & Beverage ETF
FTXG
$18.5M
$3.01M ﹤0.01%
+117,427
New +$3.16M
TOST icon
4649
CALL
Toast
TOST
$20.1B
$3.01M ﹤0.01%
232,800
+21,500
+10% +$356K
IHI icon
4650
PUT
iShares US Medical Devices ETF
IHI
$3.46B
$3.01M ﹤0.01%
59,700
+36,900
+162% +$2.01M

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.